Abbott is investigating a cybersecurity incident involving unauthorized access to a limited number of internal systems within its Cancer Diagnostics division. The company says the incident did not affect business operations, product availability, manufacturing, laboratories, or any other Abbott activities or sites. #Abbott
Information
- Victim: Abbott statement on cyber incident in Cancer Diagnostics business | Abbott Newsroom
- Website: abbott.com
- Country: United States
- Date Reported: 2026-07-16
Keypoints
- Abbott reported a cybersecurity incident affecting its Cancer Diagnostics division.
- The incident involved unauthorized access to a limited number of internal systems.
- Abbott stated that business operations were not disrupted.
- Product availability was not impacted.
- Manufacturing activities remained unaffected.
- Laboratories were not impacted by the incident.
- No other Abbott activities or sites were affected.